About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ppp2r5cGt(XP0444)Wtsi
gene trap XP0444, Wellcome Trust Sanger Institute
MGI:4331551
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Ppp2r5cGt(XP0444)Wtsi/Ppp2r5cGt(XP0444)Wtsi B6.129P2-Ppp2r5cGt(XP0444)Wtsi MGI:5661554
ht2
Ppp2r5cGt(XP0444)Wtsi/Ppp2r5c+ B6.129P2-Ppp2r5cGt(XP0444)Wtsi MGI:5661558


Genotype
MGI:5661554
hm1
Allelic
Composition
Ppp2r5cGt(XP0444)Wtsi/Ppp2r5cGt(XP0444)Wtsi
Genetic
Background
B6.129P2-Ppp2r5cGt(XP0444)Wtsi
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ppp2r5cGt(XP0444)Wtsi mutation (0 available); any Ppp2r5c mutation (47 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• intercrosses of heterozygotes indicate a ~40% loss of homozygotes at weaning age; most of these die within a day or two of birth
• no deaths are observed during fetal development

growth/size/body
• after weaning, homozygotes develop into obese adults
• by 6 months of age, homozygotes are on an average 31% heavier than control littermates
• at P5 and P21, homozygotes are smaller than wild-type or heterozygous controls
• at P1 and P20, homozygotes show a significant reduction in body weight (36% and 20%, respectively) relative to wild-type controls

cardiovascular system
• at E16, all homozygotes show a reduction in myocardial tissue due to increased cell death in alpha-actinin-positive cardiomyocytes
• at E16, homozygotes show a marked reduction in the number of cardiomyocytes expressing sarcomeric alpha-actinin relative to wild-type controls
• a reduction in the number of alpha-actinin positive Z-bands is noted in both the ventricular wall and septum
• however, no difference is observed in the abundance of E16 alpha-smooth muscle actin positive cells
• at E16, Doppler color imaging revealed mixing of right and left ventricular blood flow due to lack of ventricular septum formation
• at 6 months of age, homozygotes exhibit thinning of the ventricular septum
• however, no incomplete ventricular septa are detected in adult hearts
• at E16, only about 50% of homozygotes (11 out 21) display a clearly observable ventricular septum defect
• at E13 and E16, homozygotes display increased apoptosis in alpha-actinin positive ventricular cardiomyocytes relative to controls, as shown by TUNEL analysis
• however, no changes in fetal cardiac cell proliferation or beta-catenin levels are observed

behavior/neurological
• homozygotes show a 10-fold decrease in the amount of time they are able to maintain their balance on the rotarod relative to wild-type controls
• homozygotes release their grip on the wire lid almost immediately, with an average hang time less than 1 sec versus 17 sec in wild-type controls
• homozygotes exhibit a wobbly gait
• neonatal homozygotes are less active than wild-type or heterozygous controls

muscle
• at E16, all homozygotes show a reduction in myocardial tissue due to increased cell death in alpha-actinin-positive cardiomyocytes
• at E16, mutant hearts display reduced numbers of alpha-actinin positive Z-bands in both the ventricular wall and septum

adipose tissue
• by 6 months of age, all homozygotes exhibit excess of adipose tissue relative to control littermates

cellular
• at E13 and E16, homozygotes display increased apoptosis in alpha-actinin positive ventricular cardiomyocytes relative to controls, as shown by TUNEL analysis
• however, no changes in fetal cardiac cell proliferation or beta-catenin levels are observed

integument
• at birth, homozygotes appear paler than control littermates




Genotype
MGI:5661558
ht2
Allelic
Composition
Ppp2r5cGt(XP0444)Wtsi/Ppp2r5c+
Genetic
Background
B6.129P2-Ppp2r5cGt(XP0444)Wtsi
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ppp2r5cGt(XP0444)Wtsi mutation (0 available); any Ppp2r5c mutation (47 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• heterozygotes are normal in their appearance, development, growth, and behavior
• no intermediate growth or weight phenotype is observed





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory